These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 1701654)

  • 1. Identification of HIV gp41-specific antibodies that mediate killing of infected cells.
    Williams KL; Stumpf M; Naiman NE; Ding S; Garrett M; Gobillot T; Vézina D; Dusenbury K; Ramadoss NS; Basom R; Kim PS; Finzi A; Overbaugh J
    PLoS Pathog; 2019 Feb; 15(2):e1007572. PubMed ID: 30779811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive antigen panning for selection of HIV-1 neutralizing human monoclonal antibodies specific for gp41.
    Zhang MY; Dimitrov DS
    Methods Mol Biol; 2009; 525():175-86, xv. PubMed ID: 19252830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1.
    Leaman DP; Kinkead H; Zwick MB
    J Virol; 2010 Apr; 84(7):3382-95. PubMed ID: 20089658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41.
    Perween R; PraveenKumar M; Shrivastava T; Parray HA; Singh V; Singh S; Chiranjivi A; Jakhar K; Sonar S; Tiwari M; Reema ; Panchal AK; Sharma C; Rathore DK; Ahamed S; Samal S; Mani S; Bhattacharyya S; Das S; Luthra K; Kumar R
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108187. PubMed ID: 34649114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals.
    Corti D; Langedijk JP; Hinz A; Seaman MS; Vanzetta F; Fernandez-Rodriguez BM; Silacci C; Pinna D; Jarrossay D; Balla-Jhagjhoorsingh S; Willems B; Zekveld MJ; Dreja H; O'Sullivan E; Pade C; Orkin C; Jeffs SA; Montefiori DC; Davis D; Weissenhorn W; McKnight A; Heeney JL; Sallusto F; Sattentau QJ; Weiss RA; Lanzavecchia A
    PLoS One; 2010 Jan; 5(1):e8805. PubMed ID: 20098712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.
    Richardson TM; Stryjewski BL; Broder CC; Hoxie JA; Mascola JR; Earl PL; Doms RW
    J Virol; 1996 Feb; 70(2):753-62. PubMed ID: 8551612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities.
    Earl PL; Broder CC; Long D; Lee SA; Peterson J; Chakrabarti S; Doms RW; Moss B
    J Virol; 1994 May; 68(5):3015-26. PubMed ID: 7512157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies.
    Broder CC; Earl PL; Long D; Abedon ST; Moss B; Doms RW
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11699-703. PubMed ID: 7972127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of four novel monoclonal antibodies specific to N51(L6)C46 polypeptide simulating fusogenic core structure of GP41 subunit of HIV-1.
    Chen Z; Hong L; Li Z; Fan D; Huang Q; Wang H; Li Z; Xu Z
    Hybridoma (Larchmt); 2006 Oct; 25(5):278-82. PubMed ID: 17044783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and epitope mapping of a recombinant soluble gp160 of the human immunodeficiency virus type 1 envelope glycoprotein.
    Pasquali JL; Kieny MP; Kolbe H; Christmann D; Knapp AM
    AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1107-13. PubMed ID: 1702300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of monoclonal antibodies to human immunodeficiency virus type 1 gp41 by HIV-1 polypeptides expressed in Escherichia coli.
    Larcher C; Bröker M; Huemer HP; Sölder B; Schulz TF; Hofbauer JM; Wachter H; Dierich MP
    FEMS Microbiol Immunol; 1990 Sep; 2(2):103-10. PubMed ID: 1701654
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.